Vaccinex
A clinical-stage biotechnology company engaged in the discovery and development of targeted biotherapeutics to treat serious diseases. Learn more
Launch date
Employees
Market cap
CAD13.2m
Enterprise valuation
CAD15m (Public information from Sep 2024)
Share price
$4.55 VCNX
Rochester New York (HQ)
Authorizing premium user...